NIH Locks Doors for Secret Allergy Grant Huddle
Published Date: 4/11/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on May 13-14, 2025, to review grant applications for small businesses working on anti-infective and immune disease treatments. This private meeting protects sensitive info like trade secrets and personal details. Small businesses aiming for funding should keep an eye on this important review process happening soon.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Small-Business Grant Reviews Scheduled
If you are a small business working on anti-infective or immune-disease therapeutics, NIH will review and evaluate grant applications in a closed meeting on May 13-14, 2025 (10:00 a.m. to 6:00 p.m.). The meeting is video assisted and will be held at 5601 Fishers Lane, Rockville, MD.
Confidentiality Protects Applicants' Trade Secrets
The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, commercial property, and personal information of individuals associated with grant applications.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-06173 — Self-Regulatory Organizations; Financial Industry Regulatory Authority, Inc.; Notice of Filing of a Proposed Rule Change To Adopt FINRA Rule 6152 (Disclosure of Order Execution Information for NMS Stocks)
FINRA wants brokers to share more info about how they handle stock orders for popular U.S. stocks (NMS stocks). Starting soon, brokers will have to send their order execution data to FINRA, which will post it online for everyone to see. This change helps investors understand how well brokers are doing and could impact how trades are done, but no new fees are mentioned.
Next: 2025-06175 — National Institute of General Medical Sciences; Notice of Closed Meeting
The National Institute of General Medical Sciences is holding a private virtual meeting from April 25-28, 2025, to review special grant applications for small businesses. This closed meeting protects sensitive info like trade secrets and personal details. It affects researchers and companies seeking funding, with no direct cost changes but important decisions on who gets grants.